
Orthofix International (OFIX) Stock Forecast & Price Target
Orthofix International (OFIX) Analyst Ratings
Bulls say
Orthofix Medical is a medical device company that specializes in orthopedic and spine solutions. It has a strong global presence with two reportable segments, Global Spine and Global Limb Reconstruction, which offer a diverse range of products and solutions in their respective fields. The company's preliminary revenue report for Q1/26 exceeded expectations and management affirmed its 2026 financial guidance. However, there is a chance for higher litigation and investigation costs related to ongoing litigation connected to ex-Orthofix executives, which may impact profitability in the short term. Overall, the company remains well-positioned for growth with solid cash flow and manageable leverage levels, making it a good investment option with an OUTPERFORM rating.
Bears say
Orthofix Medical is facing a negative outlook due to uncertainties in the impacts of Medicare pricing on its bone growth stimulation business and potential failure to meet revenue or earnings estimates. This is compounded by the company's reliance on its global spine segment, which accounts for 84% of revenue and recent streamlining activities within its leadership team. These factors suggest potential challenges for the company's overall financial performance in the future.
This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.
Orthofix International (OFIX) Analyst Forecast & Price Prediction
Start investing in Orthofix International (OFIX)
Order type
Buy in
Order amount
Est. shares
0 shares